SEC FORM 3/A

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Corkal Bryan W.J.

(Last)

(First)

(Middle)

600 COUNTY ROAD D WEST

SUITE 8

(Street)

NEW BRIGHTON

55112

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
07/20/2017

3. Issuer Name and Ticker or Trading Symbol
Calyxt, Inc. [ CLXT ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)
07/20/2017

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	98,000⁽¹⁾	D
Common Stock	500⁽²⁾	I	Spouse

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option (Right to Buy)	⁽³⁾	06/14/2027	Common Stock	147,000	$13.29	D

Explanation of Responses:

1. Includes 98,000 restricted stock units with respect to Calyxt, Inc. common stock, which were granted on June 14, 2017. Due to a clerical error, the vesting of this award was incorrectly described in the original Report. The correct description is that the restricted stock units vested 20% on the date of grant and vest 10% on the first anniversary of the grant, with the remainder vesting quarterly in equal installments over the following 42 months.

2. This amended Report is also being filed to include these shares that are indirectly held by the Reporting Person and which were inadvertently omitted from the original Report.

3. Due to a clerical error, the vesting of this award was incorrectly described in the original Report. The correct description is that the award vested 20% on the date of grant, June 14, 2017, and vests 10% on the first anniversary of the grant, with the remainder vesting quarterly in equal installments over the following 42 months.

	/s/ David M. Vander Haar, attorney-in-fact for Mr. Corkal	04/16/2018
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.